|
Diabetes, Vol 45, Issue 10 1439-1445, Copyright © 1996 by American Diabetes Association
Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels
WA Chutkow, MC Simon, MM Le Beau and CF Burant
Department of Medicine, Howard Hughes Medical Institute, Chicago, Illinois, USA.
ATP-sensitive inwardly rectifying potassium channels are expressed in a
variety of tissues, including heart, skeletal, and smooth muscle, and
pancreatic beta-cells. Physiological and pharmacological studies suggest
the presence of distinct KATP channels in these tissues. Recently, the KATP
channel of beta-cells has been reconstituted in functional form by
coexpression of SUR, the sulfonylurea-binding protein, and the inwardly
rectifying K+ channel subunit, KIR6.2. In this article, we describe the
isolation of cDNAs encoding SUR-like proteins from mouse, SUR2A and SUR2B.
Northern blotting showed that the highest expression of the SUR2 isoforms
is in the heart and skeletal muscle, with lower levels in all other
tissues. By reverse transcription-polymerase chain reaction, SUR2B is
ubiquitously expressed, while the apparently alternatively spliced variant,
SUR2A, is expressed exclusively in heart. In situ hybridization shows that
the SUR2 isoforms are expressed in the parenchyma of the heart and skeletal
muscle and in the vascular structures of other tissues. Human SUR2 was
localized to chromosome 12, p12.1 by fluorescent in situ hybridization. The
structure of the predicted protein and expression pattern of SUR2 suggests
that it is the drug-binding channel-modulating subunit of the
extrapancreatic KATP channel. Differences in sequence between SUR and
between SUR2 isoforms may underlie the tissue-specific pharmacology of the
KATP channel.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Zhou, H.-J. He, R. Suzuki, K.-X. Liu, O. Tanaka, M. Sekiguchi, H. Itoh, K. Kawahara, and H. Abe
Localization of Sulfonylurea Receptor Subunits, SUR2A and SUR2B, in Rat Heart
J. Histochem. Cytochem.,
August 1, 2007;
55(8):
795 - 804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Misaki, X. Mao, Y.-F. Lin, S. Suga, G.-H. Li, Q. Liu, Y. Chang, H. Wang, M. Wakui, and J. Wu
Iptakalim, a Vascular ATP-Sensitive Potassium (KATP) Channel Opener, Closes Rat Pancreatic beta-Cell KATP Channels and Increases Insulin Release
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
871 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Giannico, P. Cortes, M. H. Baccora, C. Hassett, D. W. Taube, and J. Yee
Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells
Am J Physiol Renal Physiol,
January 1, 2007;
292(1):
F57 - F65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kakkar, B. Ye, D. A. Stoller, M. Smelley, N.-Q. Shi, K. Galles, M. Hadhazy, J. C. Makielski, and E. M. McNally
Spontaneous Coronary Vasospasm in KATP Mutant Mice Arises From a Smooth Muscle-Extrinsic Process
Circ. Res.,
March 17, 2006;
98(5):
682 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shimomura, H. Shimizu, M. Ikeda, S. Okada, M. Kakei, S. Matsumoto, and M. Mori
Fenofibrate, Troglitazone, and 15-Deoxy-{Delta}12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
1273 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seino and T. Miki
Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice
J. Physiol.,
January 15, 2004;
554(2):
295 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Meier, B Gallwitz, W E Schmidt, A Mugge, and M A Nauck
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?
Heart,
January 1, 2004;
90(1):
9 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Cartier, S. Shen, and S.-L. Shyng
Modulation of the Trafficking Efficiency and Functional Properties of ATP-sensitive Potassium Channels through a Single Amino Acid in the Sulfonylurea Receptor
J. Biol. Chem.,
February 21, 2003;
278(9):
7081 - 7090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Grover, A. J. D'Alonzo, R. B. Darbenzio, C. S. Parham, T. A. Hess, and M. S. Bathala
In Vivo Characterization of the Mitochondrial Selective KATP Opener (3R)-trans-4-((4-Chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril Monohydrochloride (BMS-191095): Cardioprotective, Hemodynamic, and Electrophysiological Effects
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
132 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hambrock, R. Preisig-Muller, U. Russ, A. Piehl, P. J. Hanley, J. Ray, J. Daut, U. Quast, and C. Derst
Four novel splice variants of sulfonylurea receptor 1
Am J Physiol Cell Physiol,
August 1, 2002;
283(2):
C587 - C598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hasko, E. A. Deitch, Z. H. Nemeth, D. G. Kuhel, and C. Szabo
Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
J. Pharmacol. Exp. Ther.,
April 1, 2002;
301(1):
103 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev.,
December 1, 2000;
52(4):
557 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Pelletier, P. A. Pahapill, P. S. Pennefather, and P. L. Carlen
Analysis of Single KATP Channels in Mammalian Dentate Gyrus Granule Cells
J Neurophysiol,
November 1, 2000;
84(5):
2291 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morishita, Y. Iwasaki, E. Yamamori, A. Nomura, N. Mutsuga, M. Yoshida, M. Asai, Y. Oiso, and H. Saito
Antidiabetic Sulfonylurea Enhances Secretagogue-Induced Adrenocorticotropin Secretion and Proopiomelanocortin Gene Expression in Vitro
Endocrinology,
September 1, 2000;
141(9):
3313 - 3318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. IKENAGA, J. P. BAST, R. W. FALLET, and P. K. CARMINES
Exaggerated Impact of ATP-Sensitive K+ Channels on Afferent Arteriolar Diameter in Diabetes Mellitus
J. Am. Soc. Nephrol.,
July 1, 2000;
11(7):
1199 - 1207.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne
Hyperinsulinism of infancy: towards an understanding of unregulated insulin release
Arch. Dis. Child. Fetal Neonatal Ed.,
March 1, 2000;
82(2):
87F - 97.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Hu, S. Wang, and B. E. Dunning
Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and beta -Cell KATP Channels
J. Pharmacol. Exp. Ther.,
December 1, 1999;
291(3):
1372 - 1379.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Gross, A. Toman, I. Uhde, C. Schwanstecher, and M. Schwanstecher
ACCELERATED COMMUNICATION: Stoichiometry of Potassium Channel Opener Action
Mol. Pharmacol.,
December 1, 1999;
56(6):
1370 - 1373.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Baron, L. van Bever, D. Monnier, A. Roatti, and A. J. Baertschi
A Novel KATP Current in Cultured Neonatal Rat Atrial Appendage Cardiomyocytes
Circ. Res.,
October 15, 1999;
85(8):
707 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Uhde, A. Toman, I. Gross, C. Schwanstecher, and M. Schwanstecher
Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors
J. Biol. Chem.,
October 1, 1999;
274(40):
28079 - 28082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev,
October 1, 1999;
79(4):
1317 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Proks, R. Ashfield, and F. M. Ashcroft
Interaction of Vanadate with the Cloned Beta Cell KATP Channel
J. Biol. Chem.,
September 3, 1999;
274(36):
25393 - 25397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dörschner, I. Uhde, C. Schwanstecher, and M. Schwanstecher
Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure
Mol. Pharmacol.,
June 1, 1999;
55(6):
1060 - 1066.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. A. Chutkow, J. C. Makielski, D. J. Nelson, C. F. Burant, and Z. Fan
Alternative Splicing of sur2 Exon 17 Regulates Nucleotide Sensitivity of the ATP-sensitive Potassium Channel
J. Biol. Chem.,
May 7, 1999;
274(19):
13656 - 13665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev.,
April 1, 1999;
20(2):
101 - 135.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. M. Gribble, P. Proks, B. E. Corkey, and F. M. Ashcroft
Mechanism of Cloned ATP-sensitive Potassium Channel Activation by Oleoyl-CoA
J. Biol. Chem.,
October 9, 1998;
273(41):
26383 - 26387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Kersten, T. J. Schmeling, K. G. Orth, P. S. Pagel, and D. C. Warltier
Acute hyperglycemia abolishes ischemic preconditioning in vivo
Am J Physiol Heart Circ Physiol,
August 1, 1998;
275(2):
H721 - H725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Gribble, S. J. Tucker, T. Haug, and F. M. Ashcroft
MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit
PNAS,
June 9, 1998;
95(12):
7185 - 7190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Wei, H. A. Kontos, J. S. Beckman, and F. M. Faraci
Antioxidants Inhibit ATP-Sensitive Potassium Channels in Cerebral Arterioles • Editorial Comment
Stroke,
April 1, 1998;
29(4):
817 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Kontos and E. P. Wei
Cerebral arteriolar dilations by KATP channel activators need L-lysine or L-arginine
Am J Physiol Heart Circ Physiol,
March 1, 1998;
274(3):
H974 - H981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. AGUILAR-BRYAN, J. P. CLEMENT IV, G. GONZALEZ, K. KUNJILWAR, A. BABENKO, and J. BRYAN
Toward Understanding the Assembly and Structure of KATP Channels
Physiol Rev,
January 1, 1998;
78(1):
227 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yokoshiki, M. Sunagawa, T. Seki, and N. Sperelakis
ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells
Am J Physiol Cell Physiol,
January 1, 1998;
274(1):
C25 - C37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. McNicholas, M. W. Nason Jr., W. B. Guggino, E. M. Schwiebert, S. C. Hebert, G. Giebisch, and M. E. Egan
A functional CFTR-NBF1 is required for ROMK2-CFTR interaction
Am J Physiol Renal Physiol,
November 1, 1997;
273(5):
F843 - F848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Fan and J. C. Makielski
Anionic Phospholipids Activate ATP-sensitive Potassium Channels
J. Biol. Chem.,
February 28, 1997;
272(9):
5388 - 5395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hernandez-Sanchez, T. L. Wood, and D. LeRoith
Developmental and Tissue-Specific Sulfonylurea Receptor Gene Expression
Endocrinology,
February 1, 1997;
138(2):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-K. Song and F. M. Ashcroft
ATP Modulation of ATP-sensitive Potassium Channel ATP Sensitivity Varies with the Type of SUR Subunit
J. Biol. Chem.,
March 2, 2001;
276(10):
7143 - 7149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hernandez-Sanchez, A. S. Basile, I. Fedorova, H. Arima, B. Stannard, A. M. Fernandez, Y. Ito, and D. LeRoith
Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death
PNAS,
March 13, 2001;
98(6):
3549 - 3554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Chutkow, V. Samuel, P. A. Hansen, J. Pu, C. R. Valdivia, J. C. Makielski, and C. F. Burant
Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle
PNAS,
September 25, 2001;
98(20):
11760 - 11764.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|